The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Soleno Therapeutics, Inc(NASDAQ:SLNO) 
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release (DCCR), a once-daily oral tablet for the treatment of Prader-Wi...
Website: http://www.soleno.life
Founded: 1999
Full Time Employees: 13
Sector: Healthcare
Industry: Diagnostics & Research
Soleno Therapeutics Days Payable Outstanding ttm (DPO)
Soleno Therapeutics Op Cashflow Per Share ttm
Soleno Therapeutics Free Cashflow Per Share ttm
Soleno Therapeutics Cash Per Share ttm
Soleno Therapeutics (GAAP) P/E ratio ttm
Soleno Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.